A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma.

@article{Engert1997APS,
  title={A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma.},
  author={Andreas Engert and Volker Diehl and R. Schnell and A Radszuhn and M T Hatwig and S. Drillich and Gisela Sch{\"o}n and Heribert Bohlen and Hans Tesch and Martin-Leo Hansmann and Stefan Barth and John D Schindler and Victor F Ghetie and Jonathan W. Uhr and Ellen S. Vitetta},
  journal={Blood},
  year={1997},
  volume={89 2},
  pages={403-10}
}
The anti-CD25 immunotoxin (IT), RFT5-SMPT-dgA, was used in a phase I dose escalation trial in patients with refractory Hodgkin's lymphoma. The IT was constructed by linking the monoclonal antibody RFT5 via a sterically hindered disulfide linker to deglycosylated ricin-A. All patients in this trial were heavily pretreated with a mean of 5 (range, 2 to 8) different prior therapies, including autologous bone marrow transplantation in 8 of 15. The mean age was 29 years (range, 19 to 34 years… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 23 references

DJP, directed against the CD30 antigen

  • RJ Kreitmann, VK Chaudhary, RW Kozak, FitzGerald
  • Int J Cancer 63:238,
  • 1995

Fourth International Symposium on Immunotoxins , R , May R , McCarthy M , Richardson J , Ghetie V , Ramillo O , Thorpe

  • B Falini, P Amlot, MJ Stone, D Cunningham, J Fay, J Newman
  • 1995

A basic interactive complex program for sta- sponse in a patient with Hodgkin’s disease refractory to chemothertistical and pharmacokinetic analysis of data

  • RC Schumaker
  • Drug Metab Rev apy. Cancer 73:1276,
  • 1994

Parkerwith ricin A - chain immunotoxins

  • F LeMaistre, FE Craig, CM Meneghetti, B McMullin
  • Leuk Lymphoma
  • 1994

Continuous hematological cancers

  • D omon, WD Figg, +8 authors ES Vitetta
  • Cancer Res
  • 1993

Response of refractory Hodgkin ’ s disease to resistant to conventional therapy . Blood 82 : 2624 ,

  • B Falini, A Bolognesi, L Flenghi, PL Tazzari, MK Broe, H Dürkopp
  • Lancet
  • 1993

Similar Papers

Loading similar papers…